Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // August 9th, 2010 // 6:43 am
Hello, everyone, and welcome to another working week - unless you happen to be on vacation. For those of us who remain very much grounded in the routine, however, today ushers in yet another series of meetings and deadlines. So please join us for the mandatory cup of stimulation as we scan the news of the world. We hope your weekend was refreshing and today is a good one. Stay in touch…
Avastin Gives Best Lung Cancer Survival Rate: Study (Reuters)
FDA Cites Dendreon For Misleading Provenge Material (Dow Jones)
Gastroenterologists Prescribing Humira Off Label For Ulcerative Colitis (PharmaTimes)
India’s Lambda Buys Biovail’s CRO (Outsourcing Pharma)
SSRIs Are Not Effective For Autism: Study (PharmaTimes)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Autism, Avastin, Biovail, Dendreon, Humira, Lamba, Lung Cancer, Provenge, Roche, SSRI, Ulcerative Colitis